The risks posed to patients with cancer by the current COVID-19 pandemic demand rapid structural changes in healthcare delivery, with many positive changes likely to continue long term. An immediate critical reassessment of trial methodology based on clinical and scientific priorities is essential to ensure the resilience of clinical cancer research and optimize patient-centered care. […]
The wide-ranging impact of the virus has starkly revealed how interconnected the world is. In this piece, GAVI, the Vaccine Alliance discusses five ways the Coronavirus pandemic could impact the global health community, including potential increase of other infectious diseases’ outbreaks and acceleration of health innovations.
What will the ultimate cost of COVID-19 be? In this insightful piece, Dr Tessa Richards discusses the wide impact on health of the COVID-19 pandemic, from the repercussions that we start to perceive to the potential and hidden figures.
COVID explained to children and young people by turning scientific and complex content into digestible information.
As you find yourself recovering from COVID-19 you may still be coming to terms with the impact the virus has had on both your body and mind. Your COVID Recovery helps you to understand what has happened and what you might expect as part of your recovery.
Researchers and ethicists are usually hesitant to deliberately expose volunteers to a virus, but thousands of people have signed up to help fast-track clinical trials. This articles discusses why human challenge trials are back on the table, the ethical questions that they raise and the challenges ahead.
The coronavirus pandemic has impacted women’s reproductive health in many ways and in all likelihood will continue to do so for years to come. In the midst of the madness, experts from two leading reproductive health businesses weigh in with their thoughts on how COVID-19 has altered the landscape for women, aspiring parents, and babies […]
During this era of COVID-19, older people and those with underlying health conditions have been considered most at risk of developing severe illness and death. However, there are other exposed populations, including pregnant women, who may also be susceptible to increased medical and social risks, as we have seen with previous disease outbreaks. This article discusses the […]
On 4 May EFPIA hosted the event “Cancer and COVID-19 – Balancing the reality of the pandemic’s budgets and the ongoing needs of cancer patients”, the second of a series of virtual events focusing on the impact of COVID-19 on cancer care. The recording of the event is now available. Participants: The Italian pharmaceutical association Farmindustria, […]
In this article, Esther Krofah – Executive Director, FasterCures, a Center of the Milken Institute – shares four takeaways from the past few weeks, from increased collaboration across industries and sectors to need for funding and capital to support smaller research organizations and companies.